AMANDA DI-MAJO: Open Payments
NPI 1508459736 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 44 payments from 11 companies in 2025. Trend: 2023 $887 · 2024 $569 · 2025 $1,001
Food & beverage: $989Education: $12
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 8 | $216 |
| Gilead Sciences, Inc. | 7 | $181 |
| Shionogi Inc | 7 | $137 |
| ABBVIE INC. | 6 | $130 |
| Paratek Pharmaceuticals, Inc. | 4 | $80 |
| Merck Sharp & Dohme LLC | 4 | $73 |
| La Jolla Pharmaceutical Company | 3 | $67 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| Insmed, Inc. | 1 | $30 |
| Melinta Therapeutics, LLC | 1 | $21 |
Products named: CABENUVA, Fetroja, NUZYRA, EMBLAVEO, DOVATO, ZEVTERA, ZERBAXA, Arikayce.
Industry payments across NC — which companies pay providers there.
